The activating receptor NKp46 is essential for the development of type 1 diabetes

被引:145
作者
Gur, Chamutal [1 ,2 ]
Porgador, Angel [3 ,4 ]
Elboim, Moran [1 ]
Gazit, Roi [1 ]
Mizrahi, Saar [1 ]
Stern-Ginossar, Noam [1 ]
Achdout, Hagit [1 ]
Ghadially, Hormas [1 ]
Dor, Yuval
Nir, Tomer
Doviner, Victoria [5 ]
Hershkovitz, Oren [3 ,4 ]
Mendelson, Michal [3 ,4 ]
Naparstek, Yaakov [2 ]
Mandelboim, Ofer [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel
[2] Hadassah Hebrew Univ Hosp, Dept Med, Jerusalem, Israel
[3] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel
[5] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel
基金
以色列科学基金会;
关键词
NATURAL-KILLER-CELL; VIRUS-INFECTED CELLS; NOD MICE; NK CELLS; PANCREATIC-ISLETS; STREPTOZOTOCIN; LYSIS; MODEL; MELLITUS; BETA;
D O I
10.1038/ni.1834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanism of action of natural killer (NK) cells in type 1 diabetes is still unknown. Here we show that the activating receptor NKp46 recognizes mouse and human ligands on pancreatic beta cells. NK cells appeared in the pancreas when insulitis progressed to type 1 diabetes, and NKp46 engagement by beta cells led to degranulation of NK cells. NKp46-deficient mice had less development of type 1 diabetes induced by injection of a low dose of streptozotocin. Injection of soluble NKp46 proteins into nonobese diabetic mice during the early phase of insulitis and the prediabetic stage prevented the development of type 1 diabetes. Our findings demonstrate that NKp46 is essential for the development of type 1 diabetes and highlight potential new therapeutic modalities for this disease.
引用
收藏
页码:121 / U37
页数:9
相关论文
共 37 条
[1]   Relationship between CD107a expression and cytotoxic activity [J].
Aktas, Esin ;
Kucuksezer, Umut Can ;
Bilgic, Sema ;
Erten, Gaye ;
Deniz, Gunnur .
CELLULAR IMMUNOLOGY, 2009, 254 (02) :149-154
[2]   Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β [J].
Alba, A. ;
Planas, R. ;
Clemente, X. ;
Carrillo, J. ;
Ampudia, R. ;
Puertas, M. -C. ;
Pastor, X. ;
Tolosa, E. ;
Pujol-Borrell, R. ;
Verdaguer, J. ;
Vives-Pi, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (03) :467-475
[3]   CD107a as a functional marker for the identification of natural killer cell activity [J].
Alter, G ;
Malenfant, JM ;
Altfeld, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 294 (1-2) :15-22
[4]   The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[5]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[6]   The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD [J].
Delovitch, TL ;
Singh, B .
IMMUNITY, 1997, 7 (06) :727-738
[7]   Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients [J].
Dotta, Francesco ;
Censini, Stefano ;
van Halteren, Astrid G. S. ;
Marselli, Lorella ;
Masini, Matilde ;
Dionisi, Sabrina ;
Mosca, Franco ;
Boggi, Ugo ;
Muda, Andrea Onetti ;
Del Prato, Stefano ;
Elliott, John F. ;
Covacci, Antonello ;
Rappuoli, Rino ;
Roep, Bart O. ;
Marchetti, Piero .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (12) :5115-5120
[8]   The natural killer cell -: Friend or foe in autoimmune disease? [J].
Flodström, M ;
Shi, FD ;
Sarvetnick, N ;
Ljunggren, HG .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (05) :432-441
[9]   Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes [J].
Flodström, M ;
Tyrberg, B ;
Eizirik, DL ;
Sandler, S .
DIABETES, 1999, 48 (04) :706-713
[10]   A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM [J].
Foulis, AK ;
McGill, M ;
Farquharson, MA ;
Hilton, DA .
DIABETOLOGIA, 1997, 40 (01) :53-61